Radioligand therapies gained momentum in 2025 with FDA’s Pluvicto approval. Here’s why 2026 could drive growth and adoption.
Celebrate International Day of Women and Girls in Science 2026 by discovering some of the most influential women shaping biotech today.
Delve into the Astellas playbook, a strategy relying on "strategic brand" and advancing on "primary focuses" at the same time ...